High Levels of Costimulatory Receptors OX40 and 4-1BB Characterize CD4 + CD28 null T Cells in Patients With Acute Coronary Syndrome
- 16 March 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 110 (6) , 857-869
Abstract
Rationale:: Patients with acute coronary syndrome (ACS) predisposed to recurrent coronary events have an expansion of a distinctive T-cell subset, the CD4 + CD28 null T cells. These cells are highly inflammatory and cytotoxic in spite of lacking the costimulatory receptor CD28, which is crucial for optimal T cell function. The mechanisms that govern CD4 + CD28 null T cell function are unknown. Objective:: Our aim was to investigate the expression and role of alternative costimulatory receptors in CD4 + CD28 null T cells in ACS. Methods and Results:: Expression of alternative costimulatory receptors (inducible costimulator, OX40, 4–1BB, cytotoxic T lymphocyte associated antigen-4, programmed death-1) was quantified in CD4 + CD28 null T cells from circulation of ACS and stable angina patients. Strikingly, in ACS, levels of OX40 and 4-1BB were significantly higher in circulating CD4 + CD28 null T cells compared to classical CD4 + CD28 + T lymphocytes. This was not observed in stable angina patients. Furthermore, CD4 + CD28 null T cells constituted an important proportion of CD4 + T lymphocytes in human atherosclerotic plaques and exhibited high levels of OX40 and 4-1BB. In addition, the ligands for OX40 and 4-1BB were present in plaques and also expressed on monocytes in circulation. Importantly, blockade of OX40 and 4-1BB reduced the ability of CD4 + CD28 null T cells to produce interferon-γ and tumor necrosis factor-α and release perforin. Conclusions:: Costimulatory pathways are altered in CD4 + CD28 null T cells in ACS. We show that the inflammatory and cytotoxic function of CD4 + CD28 null T cells can be inhibited by blocking OX40 and 4-1BB costimulatory receptors. Modulation of costimulatory receptors may allow specific targeting of this cell subset and may improve the survival of ACS patients.Keywords
This publication has 42 references indexed in Scilit:
- CD137 (4–1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic MiceCirculation, 2010
- The role of TNF superfamily members in T-cell function and diseasesNature Reviews Immunology, 2009
- Human Dendritic Cells Produce TGF-β1 under the Influence of Lung Carcinoma Cells and Prime the Differentiation of CD4+CD25+Foxp3+ Regulatory T CellsThe Journal of Immunology, 2009
- CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic MiceCirculation, 2008
- Metalloproteinases and Vulnerable Atherosclerotic PlaquesTrends in Cardiovascular Medicine, 2007
- Unusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary EventsJACC, 2007
- Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) Pathway Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- The B7–CD28 superfamilyNature Reviews Immunology, 2002
- T-cell regulation by CD28 and CTLA-4Nature Reviews Immunology, 2001
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994